Animal Pharm is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Companion Animals

Set Alert for Companion Animals

Zoetis to discontinue sales of equine wormer

Zoetis' Equitape praziquantel-only wormer for horses will be discontinued from the firm's equine product range in October 2018.

United Kingdom Antiparasitics

Animal Pharm seeks freelance special reports writers

Animal Pharm is looking for new authors for its animal health industry reports team.

Policy & Regulation Companion Animals

Boehringer, Jurox secure supplemental FDA approvals

Boehringer Ingelheim Vetmedica has gained a supplemental US approval for Cystorelin (gonadorelin), which is used in reproductive synchrony programs for cattle.

United States Boehringer Ingelheim Animal Health

Elanco adds ex-Zoetis director as head of companion animal R&D

Patrick Meeus has become Elanco's new senior director of global companion animal product development.

People Elanco

KindredBio becomes commercial entity as Mirataz goes on sale

US pet therapeutics company Kindred Biosciences has become a commercial entity around six years after it was founded.

United States Kindred Biosciences

Animalcare to launch Cortacare in Q4, ahead of 16 more prioritized candidates

UK firm Animalcare has pencilled a fourth-quarter launch date for its recently-approved Cortacare canine dermatology product.

Generics Pharmaceuticals

Animal health focus allows TyraTech to think big with its revenues, pipeline

Last year, TyraTech did the opposite of many companies and offloaded its human health business. Now with a focus on animal health, the Morrisville, North Carolina-based firm can pursue a more disciplined growth strategy. Animal Pharm editor Joseph Harvey spoke to the company's chief executive Bruno Jactel.

Antiparasitics Food Animals

Boehringer's Zactran, MSD's Bravecto secure Japanese extensions

Boehringer Ingelheim Animal Health has secured Japanese approval for Zactran (gamithromycin) as an antibiotic treatment of swine respiratory disease.

Japan Boehringer Ingelheim Animal Health

CannPal in Eurofins collaboration to expand cannabis therapeutic into cats

Australian firm CannPal Therapeutics has signed a research agreement with Eurofins Animal Health to develop a cannabis-derived pain therapeutic for cats.

Companion Animals Pharmaceuticals

Zinpro launches canine, livestock dermatology supplements

US firm Zinpro has launched new nutritional dermatology products for dogs and livestock.

Dermatology Canine

Bayer to work with Mitsui on new antiparasitic compounds

Bayer Animal Health has teamed up with Japanese firm Mitsui Chemicals Agro (MCAG) in its search for novel parasite prevention.

Deals R&D

Avivagen OxC-beta approval to lay foundation for livestock route in Canada

Canadian firm Avivagen has gained authorization from the Veterinary Drugs Directorate of Health Canada to use its OxC-beta technology in pet supplements.

Canada Philippines
See All
Advertisement
UsernamePublicRestriction

Register